Global disparities exist in the burden of cervical cancer. Only 11 out of the 185 countries and regions reported an age-standardized incidence rates (ASIR) lower than the World Health Organization’s ...

Cervical cancer constitutes a formidable health challenge imperiling the well-being and lives of women globally, particularly in underdeveloped nations. The survival rates among patients diagnosed ...

Concomitant therapies in intermediate-risk cervical cancer began in the late 1990s ... “The idea here was that if the pathology report indicated a larger tumor involving the lymphatics, the ...

Agnes Kathrine Lie, MD, PhD, Department of Pathology, and Gunnar Kristensen ... available HPV tests in the Norwegian Coordinated Cervical Cancer Screening Program, financially supported by ...

A safe alternative to clinician-administered tests, the self-test for HPV can help prevent cervical cancer. Read more at ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...